MODL-20. A BIOBANK OF ~100 PATIENT-DERIVED MODELS REPRESENTING BIOLOGICAL HETEROGENEITY AND DISTINCT THERAPEUTIC DEPENDENCIES IN PAEDIATRIC HIGH GRADE GLIOMA AND DIPG
Diana Carvalho(Institute of Cancer Research), Chris Jones(North Carolina State University), Darren Hargrave(Great Ormond Street Hospital), Jane Pears(Our Lady's Hospital), Fernando Carceller, Michael Hubank(Royal Marsden Hospital), Matthew Clarke(Institute of Cancer Research), Valeria Molinari(Institute of Cancer Research), Andrew S. Moore(Children's Health Queensland Hospital and Health Service), Elisa Izquierdo(Institute of Cancer Research), Sara Temelso(Institute of Cancer Research), Anna Burford(Cancer Research Institute of the Slovak Academy of Sciences), Alan Mackay(Institute of Cancer Research), Rebecca F. Rogers(Institute of Cancer Research), Ketty Kessler(Institute of Cancer Research), Lynley V. Marshall(Royal Marsden Hospital), Janat Fazal Salom(Institute of Cancer Research), Mariama Fofana(Institute of Cancer Research), Ángel M. Carcaboso(Hospital Sant Joan de Déu Barcelona), Simon P. Robinson(Institute of Cancer Research), Elisabet Potente Fernandez(Institute of Cancer Research), Natalie Simon(Institute of Cancer Research), Maria Vinci(Cancer Research UK), Lynn Bjerke(Institute of Cancer Research), Jessica K.R. Boult(Institute of Cancer Research)
Cited by 2
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k